Heart Failure in Patients with Chronic Kidney Disease

被引:7
|
作者
Xanthopoulos, Andrew [1 ]
Papamichail, Adamantia [2 ]
Briasoulis, Alexandros [2 ]
Loritis, Konstantinos [2 ]
Bourazana, Angeliki [1 ]
Magouliotis, Dimitrios E. [3 ]
Sarafidis, Pantelis [4 ]
Stefanidis, Ioannis [5 ]
Skoularigis, John [1 ]
Triposkiadis, Filippos [6 ]
机构
[1] Univ Hosp Larissa, Dept Cardiol, Larisa 41110, Greece
[2] Natl & Kapodistrian Univ Athens, Alexandra Hosp, Fac Med, Amyloidosis Ctr,Dept Clin Therapeut, Athens 15772, Greece
[3] Univ Thessaly, Dept Cardiothorac Surg, Unit Qual Improvement, Larisa 41110, Greece
[4] Aristotle Univ Thessaloniki, Hippokrat Hosp, Dept Nephrol, Thessaloniki 54124, Greece
[5] Univ Thessaly, Fac Med, Dept Nephrol, Larisa 41110, Greece
[6] European Univ Cyprus, Sch Med, CY-2404 Nicosia, Cyprus
关键词
chronic kidney disease; heart failure; beta-blockers; renin-angiotensin aldosterone system inhibitors; angiotensin receptor/neprilysin inhibitor; sodium glucose cotransporter 2 inhibitor; ANGIOTENSIN-CONVERTING ENZYME; WORSENING RENAL-FUNCTION; REDUCED EJECTION FRACTION; BETA-BLOCKERS; IRON-DEFICIENCY; ALDOSTERONE BREAKTHROUGH; ATHEROSCLEROSIS RISK; DIALYSIS PATIENTS; BLOOD-PRESSURE; OUTCOMES;
D O I
10.3390/jcm12186105
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The function of the kidney is tightly linked to the function of the heart. Dysfunction/disease of the kidney may initiate, accentuate, or precipitate of the cardiac dysfunction/disease and vice versa, contributing to a negative spiral. Further, the reciprocal association between the heart and the kidney may occur on top of other entities, usually diabetes, hypertension, and atherosclerosis, simultaneously affecting the two organs. Chronic kidney disease (CKD) can influence cardiac function through altered hemodynamics and salt and water retention, leading to venous congestion and therefore, not surprisingly, to heart failure (HF). Management of HF in CKD is challenging due to several factors, including complex interplays between these two conditions, the effect of kidney dysfunction on the metabolism of HF medications, the effect of HF medications on kidney function, and the high risk for anemia and hyperkalemia. As a result, in most HF trials, patients with severe renal impairment (i.e., eGFR 30 mL/min/1.73 m(2) or less) are excluded. The present review discusses the epidemiology, pathophysiology, and current medical management in patients with HF developing in the context of CKD.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Chronic kidney disease in diabetic chronic heart failure patients
    Reznik, E. V.
    Lazarev, V. A.
    Komissarova, M. S.
    Presnova, E. D.
    Nikitin, I. G.
    Salikov, A. V.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 279 - 279
  • [2] Management of Heart Failure in Patients with Chronic Kidney Disease
    Ryan, David K.
    Banerjee, Debasish
    Jouhra, Fadi
    [J]. EUROPEAN CARDIOLOGY REVIEW, 2022, 17
  • [3] Congestive Heart Failure in Patients with Chronic Kidney Disease
    Poskurica, Mileta
    Petrovic, Dejan
    [J]. SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2014, 142 (11-12) : 747 - 755
  • [4] Management of patients with heart failure and chronic kidney disease
    Wu, Lingling
    Rodriguez, Mario
    El Hachem, Karim
    Tang, W. H. Wilson
    Krittanawong, Chayakrit
    [J]. HEART FAILURE REVIEWS, 2024, 29 (05) : 989 - 1023
  • [5] Chronic Kidney Disease in Hospitalized Patients with Heart Failure
    Nakamura, Satoko
    Anzai, Toshihisa
    Kawano, Yuhei
    [J]. JOURNAL OF CARDIAC FAILURE, 2014, 20 (10) : S193 - S193
  • [6] CHRONIC KIDNEY DISEASE IN ASIAN PATIENTS WITH HEART FAILURE
    Tromp, Jasper
    Teng, Katherine T. H.
    Tay, Wan Ting
    Anand, Inder
    Zhang, Shu
    Shimizu, Wataru
    Narasimhan, Calambur
    Park, S. W.
    Yu, Cheuk-Man
    Ngarmukos, Tachapong
    Omar, Razali
    Reyes, Eugene B.
    Hung, Chung-Lieh
    Ling, Lieng
    Yap, Jonathan
    MacDonald, Michael Ross
    Richards, Mark
    Lam, Carolyn
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 933 - 933
  • [7] Prevention of Heart Failure in Patients with Chronic Kidney Disease
    Raghban A.
    Kirsop J.
    Tang W.H.W.
    [J]. Current Cardiovascular Risk Reports, 2015, 9 (1) : 1 - 11
  • [8] OPTIMAL MANAGEMENT OF CHRONIC HEART FAILURE IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Zachariah, Donah
    Kaira, Philip A.
    Kaira, Paul R.
    [J]. JOURNAL OF RENAL CARE, 2009, 35 (01) : 2 - 10
  • [9] CHRONIC KIDNEY DISEASE IN THE EVALUATION OF COMORBIDITY IN PATIENTS WITH CHRONIC HEART FAILURE
    Efremova, E.
    Shutov, A.
    [J]. ATHEROSCLEROSIS, 2020, 315 : E263 - E264
  • [10] Xanthine metabolism in chronic heart failure patients with chronic kidney disease
    Smolianyk, K. Kateryna
    Bilchenko, A.
    Kolomiiets, M.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 138 - 138